钙通道阻滞药预防动脉粥样硬化

被引:1
作者
孙宁玲
机构
[1] 北京大学人民医院心内科、高血压科
关键词
动脉粥样硬化; ACEI; 临床试验; 冠心病患者; 高血压患者; 动脉硬化; CCB; 氨氯地平; 钙通道; 慢通道;
D O I
暂无
中图分类号
R543.2 [肺动、静脉疾病];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:278 / 281
页数:4
相关论文
共 9 条
[1]  
Effect of am lodipine on the progression of atherosclerosis and the occurrence of clinical events.PREVENT Investigators. Pitt B,Byington RP,Furberg CD,et al. Circulation . 2000
[2]  
D ifferential effects of nifedipine and co-am ilozide on the progression of early carotid wall changes. Simon A,Gariepy J,Moyse D,et al. Circulation . 2001
[3]  
Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension.Systolic Hypertension in China (Syst-China) Collaborative Group. Liu L,W ang JG,Gong L,et al. Journal of Hypertension . 1998
[4]  
Random ised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension.The Systolic Hypertension in Europe(Syst-Eur) Trial Investigators. Staessen JA,Fagard R,Thijs L,et al. The Lancet . 1997
[5]  
Random ised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic D iltiazem (NORD IL) study. Hansson L,Hedner T,Lund-Johansen P,et al. The Lancet . 2000
[6]  
Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a random ized controlled trial. N issen SE,Tuzcu EM,Libby P,et al. The Journal of The American Medical Association . 2004
[7]  
Major outcomes in high-risk hypertensive patients random ized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Collaborative Research Group. The Journal of The American Medical Association . 2002
[8]  
Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with symptomatic stable angina and hypertension: theACTION trial. Lubsen J,W agener G,K irwan BA,et al. Journal of Hypertension . 2005
[9]  
Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis:principal results of the European Lacidipine Study on Atherosclerosis(ELSA), a random ized, double-blind, long-term trial. ZanchettiA,BondMG,HennigM,et al. Circulation . 2002